Michelle Sidor

Michelle Sidor

Company: Alchemab Therapeutics Ltd

Job title: Director of Neuroscience


Mining Patient Resiliency-Associated Targets for Novel Antibody Therapeutics: Discovery of the CD33 antibody, ATLX-1088 11:30 am

Sequencing the B cell repertoire from resilient patient populations to look for protective auto-antibodies in an unbiased manner Identifying resilient autoantibodies to uncover novel targets and pathways for target discovery Harnessing the neuroprotective activity of microglia within the 1088 program as a novel antibody therapeuticRead more

day: Discovery Track AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.